Prise en charge et traitement de la dermatite atopique dans les soins primaires
Résumé
La dermatite atopique (DA) est une maladie inflammatoire chronique de la peau, récidivante et rémittente, caractérisée par un érythème, un œdème, une xérose, des érosions/excoriations, un suintement et des croûtes. Elle débute généralement durant l’enfance et souvent au cours de la petite enfance. La maladie peut évoluer en dents de scie et, chez de nombreux patients, elle s’atténue, voire disparaît avec le temps. Les variations saisonnières sont fréquentes, la plupart des patients voyant leurs symptômes s’aggraver en hiver, en particulier au Canada.
Références
Gooderham MJ, Bissonnette R, Grewal P, Lansang P, Papp KA, Hong CH. Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. Section II: tools for assessing the severity of atopic dermatitis. J Cutan Med Surg. 2018 Nov;22(1_suppl):10S-6S.
Asher MI, Rutter CE, Bissell K, Chiang CY, El Sony A, Ellwood E, Ellwood P, García-Marcos L, Marks GB, Morales E, Mortimer K. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I Cross-sectional study. Lancet. 2021 Oct 30;398(10311):1569-80.
Weiss ST. Eat dirt—the hygiene hypothesis and allergic diseases. N Engl J Med. 2002 Sep 19;347(12):930-1.
Hill DA, Spergel JM. The atopic march: critical evidence and clinical relevance. Ann Allergy Asthma Immunol. 2018 Feb 1;120(2):131-7.
Kirchhof MG, Landells I, Lynde CW, Gooderham MJ, Hong CH. Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. Section I: pathophysiology of atopic dermatitis and implications for systemic therapy. J Cutan Med Surg. 2018 Nov;22(1_suppl):6S-9S.
Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-51.
Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003 Dec 1;49(6):1088-95.
Gooderham M, Lynde CW, Papp K, Bourcier M, Guenther L, Gulliver W, Hong CH, Poulin Y, Sussman G, Vender R. Review of systemic treatment options for adult atopic dermatitis. J Cutan Med Surg. 2017 Jan;21(1):31-9.
Gabros S, Nessel TA, Zito PM. Topical corticosteroids. StatPearls Publishing; 2018.
Faergemann J, Christensen O, Sjövall P, Johnsson A, Hersle K, Nordin P, Edmar B, Svensson Å. An open study of efficacy and safety of long‐term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2000 Sep;14(5):393-6.
Wollenberg A, Reitamo S, Atzori F, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J, Deleuran M, European Tacrolimus Ointment Study Group. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy. 2008 Jun;63(6):742-50.
Weidinger S, Baurecht H, Schmitt J. A 5‐year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal. Br J Dermatol. 2017; 177(4):999-1003.
Arcutis Biotherapeutics, Inc. Arcutis announces positive topline results from INTEGUMENT-1 pivotal Phase 3 trial of Roflumilast cream in atopic dermatitis in adults and children aged six years and older. Globe Newswire. 2022 Nov 15. https://www.arcutis.com/arcutis-announces-positive-topline-results-from-integument-1-pivotal-phase-3-trial-of-roflumilast-cream-in-atopic-dermatitis-in-adults-and-children-aged-six-years-and-older.
Peppers J, Paller AS, Maeda-Chubachi T, Wu S, Robbins K, Gallagher K, Kraus JE. A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis. J Am Acad Dermatol. 2019 Jan 1;80(1):89-98.
Hong CH, Gooderham MJ, Albrecht L, et al. Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. Section V: consensus statements on the assessment and management of adult patients with moderate-to-severe atopic dermatitis. J Cutan Med Surg. 2018;22(1_suppl):30S-35S.
Publié
Versions
- 2023-03-28 (2)
- 2023-03-28 (1)
Comment citer
Numéro
Rubrique
Licence
© Canadian Primary Care Today 2023
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
